摘要
糖尿病视网膜病变是糖尿病最常见的并发症之一。大量文献表明氧化应激在糖尿病视网膜病变中发挥着重要作用。因此可以假设抗氧化疗法或许对糖尿病视网膜病变具有保护性。花青素是重要的天然生物活性色素,是多种植物的果实、叶子、种子、茎和花的红-蓝颜色的原因。除了颜色外,花青素被公认为具有促健康的植物化学物质且在一些退行性疾病中具有防止氧化应激潜在特性。它们也有多种生物活性,包括抗炎、抗菌、抗肿瘤和心脏保护特性。一些报道进一步表明了花青素在预防和/或防止眼部疾病中的作用,但仍需更多的研究来分析其在糖尿病视网膜病变中作为替代疗法的潜能。本文综述了有关花青素在糖尿病视网膜病变中益处的现有文献。
关键词: 花青素,抗氧化剂,浆果,糖尿病,糖尿病性视网膜病变。
Current Medicinal Chemistry
Title:Anthocyanins as a Potential Therapy for Diabetic Retinopathy
Volume: 22 Issue: 1
Author(s): S.F. Nabavi, S. Habtemariam, M. Daglia, N. Shafighi, A.J. Barber and S.M. Nabavi
Affiliation:
关键词: 花青素,抗氧化剂,浆果,糖尿病,糖尿病性视网膜病变。
摘要: Diabetic retinopathy is one of the most common complications of diabetes. A plethora of literature indicates that oxidative stress may play a central role in the pathogenesis of diabetic retinopathy. One could thus hypothesise that antioxidant therapies may be protective for diabetic retinopathy. Anthocyanins are important natural bioactive pigments responsible for red-blue colour of fruits, leaves, seeds, stems and flowers in a variety of plant species. Apart from their colours, anthocyanins are known to be health-promoting phytochemicals with potential properties useful to protect against oxidative stress in some degenerative diseases. They also have a variety of biological properties including anti-inflammatory, antibacterial, anticancer, and cardio-protective properties. Some reports further suggest a therapeutic role of anthocyanins to prevent and/or protect against ocular diseases but more studies are needed to examine their potential as alternative therapy to diabetic retinopathy. The present article reviews the available literature concerning the beneficial role of anthocyanins in diabetic retinopathy.
Export Options
About this article
Cite this article as:
S.F. Nabavi, S. Habtemariam, M. Daglia, N. Shafighi, A.J. Barber and Nabavi S.M., Anthocyanins as a Potential Therapy for Diabetic Retinopathy, Current Medicinal Chemistry 2015; 22 (1) . https://dx.doi.org/10.2174/0929867321666140815123852
DOI https://dx.doi.org/10.2174/0929867321666140815123852 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Lipid Lowering Therapy in the Elderly: Is there a Benefit?
Current Pharmaceutical Design Antimicrobial and Biofilm Inhibiting Diketopiperazines
Current Medicinal Chemistry Menopause and its Cardiometabolic Consequences: Current Perspectives
Current Vascular Pharmacology Recent Trends in Development of Fermented Milks
Current Nutrition & Food Science Lipid Management and Peripheral Arterial Disease
Current Drug Targets Controversies in Anticoagulant Therapy in Vitreo-Retinal Surgery
Current Pharmaceutical Design The Role of Mineralocorticoid Receptor Antagonists in the Management of Heart Failure with Preserved Ejection Fraction
Current Pharmaceutical Design The Role of the Brain Renin-Angiotensin System in Neurodegenerative Disorders
Current Alzheimer Research Anti Citrullinated Protein Antibodies and Mechanism of Action of Common Disease Modifying Drugs - Insights in Pathomechanisms of Autoimmunity
Current Pharmaceutical Design Atypical Presentation Of Anti-Retroviral Therapy Induced Lactic Acidosis as Acute Right Ventricular Failure And Severe Pulmonary Hypertension
New Emirates Medical Journal Cellular Iron Homeostasis and Therapeutic Implications of Iron Chelators in Cancer
Current Pharmaceutical Biotechnology Understanding the Role of Aldose Reductase in Ocular Inflammation
Current Molecular Medicine Cell and Gene Therapies in Cardiovascular Disease with Special Focus on the No Option Patient
Current Gene Therapy Getting Patients to Target- Implementing the Guidelines
Current Vascular Pharmacology Relationship Between Proinsulin Level and Cardiovascular Risk Factors Clustering: An Epidemiological Study
Vascular Disease Prevention (Discontinued) Lipoprotein(a): Medical Treatment Options for an Elusive Molecule
Current Pharmaceutical Design Oral Inflammation and Bacteremia: Implications for Chronic and Acute Systemic Diseases Involving Major Organs
Cardiovascular & Hematological Disorders-Drug Targets The Biology and Therapeutic Potential of the DDAH/ADMA Pathway
Current Pharmaceutical Design Effects of Intravenous Apo A-I, HDLs and Apo A-I/Phospholipid Discs on Vascular Metabolism and Atherosclerosis in Animals and Humans
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Implication of Gut Microbiota in Human Health
CNS & Neurological Disorders - Drug Targets